Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.

作者: Susan Cu-Uvin , Brad Snyder , Joseph W. Hogan , Barbara Clayman , Keerti V. Shah

DOI:

关键词:

摘要: The association between seropositivity to virus-like particles (VLP) of human papillomavirus (HPV) types 16, 18, 31, 35, or 45 and subsequent cervical HPV infection was examined in 829 women with HIV 413 risk-matched HIV-negative women. We found no statistically significant differences HPV-seropositive HPV-seronegative the risk a new homologous type, exception reduced infections 4.5 years beyond baseline serology measurement HIV-positive [hazard ratio, 0.21; 95% confidence interval (CI), 0.05-0.89]. Among women, not associated related viruses "other" groups. slightly increased group-related viruses, but were only for 16 group (hazard 1.6; CI, 1.1-2.3) 18-seropositive 31-seropositive 1.45; 1.0-2.0). lack protective immune effect from natural is most likely due low level antibody elicited by and/or potential reactivation HPV, especially

参考文章(28)
Terry M. Therneau, Patricia M. Grambsch, Modeling Survival Data: Extending the Cox Model ,(2000)
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
Linda Ahdieh, Robert S. Klein, Robert Burk, Susan Cu‐Uvin, Paula Schuman, Ann Duerr, Mahboobeh Safaeian, Jacquie Astemborski, Richard Daniel, Keerti Shah, Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. The Journal of Infectious Diseases. ,vol. 184, pp. 682- 690 ,(2001) , 10.1086/323081
R. D. Burk, G. Y. F. Ho, L. Beardsley, M. Lempa, M. Peters, R. Bierman, Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. The Journal of Infectious Diseases. ,vol. 174, pp. 679- 689 ,(1996) , 10.1093/INFDIS/174.4.679
M. Evander, K. Edlund, A. Gustafsson, M. Jonsson, R. Karlsson, E. Rylander, G. Wadell, Human Papillomavirus Infection Is Transient in Young Women: A PopulationBased Cohort Study The Journal of Infectious Diseases. ,vol. 171, pp. 1026- 1030 ,(1995) , 10.1093/INFDIS/171.4.1026
John T. Schiller, Douglas R. Lowy, Papillomavirus-like particles and HPV vaccine development. Seminars in Cancer Biology. ,vol. 7, pp. 373- 382 ,(1996) , 10.1006/SCBI.1996.0046
D. K. Smith, D. L. Warren, D. Vlahov, P. Schuman, M. D. Stein, B. L. Greenberg, S. D. Holmberg, , Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. American Journal of Epidemiology. ,vol. 146, pp. 459- 469 ,(1997) , 10.1093/OXFORDJOURNALS.AJE.A009299
Denise J Jamieson, Ann Duerr, Robert Burk, Robert S Klein, Pangaja Paramsothy, Paula Schuman, Susan Cu-Uvin, Keerti Shah, HIV Epidemiology Research Study (HERS) Group, Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. American Journal of Obstetrics and Gynecology. ,vol. 186, pp. 21- 27 ,(2002) , 10.1067/MOB.2002.119776
STANLEY A. PLOTKIN, Immunologic correlates of protection induced by vaccination Pediatric Infectious Disease Journal. ,vol. 20, pp. 63- 75 ,(2001) , 10.1097/00006454-200101000-00013
Laura A. Koutsky, Kevin A. Ault, Cosette M. Wheeler, Darron R. Brown, Eliav Barr, Frances B. Alvarez, Lisa M. Chiacchierini, Kathrin U. Jansen, A controlled trial of a human papillomavirus type 16 vaccine. The New England Journal of Medicine. ,vol. 347, pp. 1645- 1651 ,(2002) , 10.1056/NEJMOA020586